Vitamin D and inflammatory bowel disease

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

This chapter reviews the immunoregulatory role of vitamin D and its effect on the pathology of inflammatory bowel disease (IBD). Following this, it discusses the epidemiological evidence connecting vitamin D deficiency to IBD severity and the data from animal models of experimental IBD. It also proposes the vitamin D hypothesis, which suggests that vitamin D status may be an environmental factor involved in the development of IBD. Finally the chapter reviews the current treatment options for IBD patients and explains how vitamin D might be used as an alternative or a supplemental treatment for patients with IBD. Vitamin D, in vitamin-D-insufficient patients, and its active metabolites and analogs could be a safe and effective adjunct to the therapies available to treat or prevent IBD. Unfortunately, clinical interventions have not been done to look at the effects of vitamin D on IBD disease in humans; based on the extensive data in animal models several studies have been proposed. Issues that need to be addressed include-defining the appropriate dose of the vitamin D compound to be used, effect of other therapies a patient is on, and whether or not patients with either Ulcerative colitis or celiac disease or both can benefit.

Original languageEnglish (US)
Title of host publicationVitamin D
PublisherElsevier Inc.
Pages1879-1889
Number of pages11
ISBN (Print)9780123819789
DOIs
StatePublished - Dec 1 2011

Fingerprint

Inflammatory Bowel Diseases
Vitamin D
Animal Models
Vitamin D Deficiency
Celiac Disease
Therapeutics
Ulcerative Colitis
Pathology

All Science Journal Classification (ASJC) codes

  • Dentistry(all)
  • Medicine(all)

Cite this

Bruce, Danny ; Cantorna, Margherita T. / Vitamin D and inflammatory bowel disease. Vitamin D. Elsevier Inc., 2011. pp. 1879-1889
@inbook{64c5816723fb4045a1046aa6f0c6fe6a,
title = "Vitamin D and inflammatory bowel disease",
abstract = "This chapter reviews the immunoregulatory role of vitamin D and its effect on the pathology of inflammatory bowel disease (IBD). Following this, it discusses the epidemiological evidence connecting vitamin D deficiency to IBD severity and the data from animal models of experimental IBD. It also proposes the vitamin D hypothesis, which suggests that vitamin D status may be an environmental factor involved in the development of IBD. Finally the chapter reviews the current treatment options for IBD patients and explains how vitamin D might be used as an alternative or a supplemental treatment for patients with IBD. Vitamin D, in vitamin-D-insufficient patients, and its active metabolites and analogs could be a safe and effective adjunct to the therapies available to treat or prevent IBD. Unfortunately, clinical interventions have not been done to look at the effects of vitamin D on IBD disease in humans; based on the extensive data in animal models several studies have been proposed. Issues that need to be addressed include-defining the appropriate dose of the vitamin D compound to be used, effect of other therapies a patient is on, and whether or not patients with either Ulcerative colitis or celiac disease or both can benefit.",
author = "Danny Bruce and Cantorna, {Margherita T.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/B978-0-12-381978-9.10096-4",
language = "English (US)",
isbn = "9780123819789",
pages = "1879--1889",
booktitle = "Vitamin D",
publisher = "Elsevier Inc.",
address = "United States",

}

Vitamin D and inflammatory bowel disease. / Bruce, Danny; Cantorna, Margherita T.

Vitamin D. Elsevier Inc., 2011. p. 1879-1889.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Vitamin D and inflammatory bowel disease

AU - Bruce, Danny

AU - Cantorna, Margherita T.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - This chapter reviews the immunoregulatory role of vitamin D and its effect on the pathology of inflammatory bowel disease (IBD). Following this, it discusses the epidemiological evidence connecting vitamin D deficiency to IBD severity and the data from animal models of experimental IBD. It also proposes the vitamin D hypothesis, which suggests that vitamin D status may be an environmental factor involved in the development of IBD. Finally the chapter reviews the current treatment options for IBD patients and explains how vitamin D might be used as an alternative or a supplemental treatment for patients with IBD. Vitamin D, in vitamin-D-insufficient patients, and its active metabolites and analogs could be a safe and effective adjunct to the therapies available to treat or prevent IBD. Unfortunately, clinical interventions have not been done to look at the effects of vitamin D on IBD disease in humans; based on the extensive data in animal models several studies have been proposed. Issues that need to be addressed include-defining the appropriate dose of the vitamin D compound to be used, effect of other therapies a patient is on, and whether or not patients with either Ulcerative colitis or celiac disease or both can benefit.

AB - This chapter reviews the immunoregulatory role of vitamin D and its effect on the pathology of inflammatory bowel disease (IBD). Following this, it discusses the epidemiological evidence connecting vitamin D deficiency to IBD severity and the data from animal models of experimental IBD. It also proposes the vitamin D hypothesis, which suggests that vitamin D status may be an environmental factor involved in the development of IBD. Finally the chapter reviews the current treatment options for IBD patients and explains how vitamin D might be used as an alternative or a supplemental treatment for patients with IBD. Vitamin D, in vitamin-D-insufficient patients, and its active metabolites and analogs could be a safe and effective adjunct to the therapies available to treat or prevent IBD. Unfortunately, clinical interventions have not been done to look at the effects of vitamin D on IBD disease in humans; based on the extensive data in animal models several studies have been proposed. Issues that need to be addressed include-defining the appropriate dose of the vitamin D compound to be used, effect of other therapies a patient is on, and whether or not patients with either Ulcerative colitis or celiac disease or both can benefit.

UR - http://www.scopus.com/inward/record.url?scp=84655173722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84655173722&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-381978-9.10096-4

DO - 10.1016/B978-0-12-381978-9.10096-4

M3 - Chapter

AN - SCOPUS:84655173722

SN - 9780123819789

SP - 1879

EP - 1889

BT - Vitamin D

PB - Elsevier Inc.

ER -